Carvedilol Tablet, Film Coated
Product Images NDC 63629-4070

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 63629-4070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 01

Chemical structure of carvedilol, showing its molecular framework including an indole moiety and a methoxyphenyl group linked by a side chain with hydroxyl and amine groups.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 02

A line graph depicting % Mortality over Months comparing Carvedilol and Placebo groups. The Carvedilol group shows a lower mortality rate than the Placebo group. A p-value of 0.0014 indicates statistical significance between the two curves.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 03

A forest plot chart showing hazard ratios across different patient subgroups including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and use of spironolactone. Each subgroup is represented by a point estimate with confidence intervals on a horizontal axis ranging from approximately 0.0 to 2.0, with a vertical reference line at 1.0. The chart summarizes comparative risk data for the patient groups.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 04

A line graph comparing mortality percentages over 24 months between Carvedilol and placebo groups. The x-axis represents time in months, and the y-axis shows the percentage mortality. The graph indicates lower mortality rates for Carvedilol compared to placebo with a p-value of 0.03.*

FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 05

A forest plot chart illustrating hazard ratios for various patient subgroups related to clinical outcomes. The subgroups include age, gender, myocardial infarction timing, prior beta-blocker use, Killip classification, thrombolytic therapy, angioplasty for MI, congestive heart failure history, diuretic use, angina, hypertension, diabetes, heart rate, systolic blood pressure, and all patients overall.*

FDA Label Image

Label Image (Lbl636294070)

Carvedilol 25 mg film-coated tablet label packaged by Bryant Ranch Prepack, Burbank, CA. The label includes comparison to Coreg 25 mg tablet by Aurobindo Pharma Limited. Package quantity is 100 tablets, with an expiration date format MM/YY. Storage instructions specify room temperature of 20-25°C (68-77°F). A barcode and NDC 63629-4070 are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.